NFKBIA and hepatocellular carcinoma: To examine whether decreased levels of NFKBIA expression renders TNBC cells resistant to XPO1 inhibition, we treated BT-549 and HCC-1806 NFKBIA knockdown cell lines with selinexor and measured the cellular viability.